🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
25.67
-1.60 (-5.87%)
At close: Nov 20, 2026

SHA:688765 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-138.17-157.04-151.37-186.96-143.58-134.04
Depreciation & Amortization
68.9265.5761.4447.8212.9210.04
Other Amortization
0.730.720.40.01--
Loss (Gain) From Sale of Assets
-2.64-3.791.28-1.01-0.3311.27
Asset Writedown & Restructuring Costs
0.710.710.481.111.3-
Loss (Gain) From Sale of Investments
-8.97-0.91----
Provision & Write-off of Bad Debts
-0.310.02-00.01-0.050
Other Operating Activities
6.197.635.190.990.340.8
Change in Accounts Receivable
-96.03-77.56-9.9518.19-7.88-21.29
Change in Inventory
-166.55-73.34-14.29-10.06-13.150.86
Change in Accounts Payable
147.9886.5132.2-16.2660.8226.57
Change in Other Net Operating Assets
20.5523.1621.123.3223.217.82
Operating Cash Flow
-167.58-128.32-53.53-122.85-66.4-87.97
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-602.77-538.06-166.84-101.59-358.29-175.47
Sale of Property, Plant & Equipment
--40.48-0.68-
Investment in Securities
-510-1,311----
Investing Cash Flow
-1,113-1,849-126.37-101.59-357.61-175.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-411.59133.5577.9830.49.9
Total Debt Issued
419.63411.59133.5577.9830.49.9
Long-Term Debt Repaid
--337.86-23.85-1-16.27-20.29
Lease Payments
-11.98-16.05-0.35---0.39
Total Debt Repaid
-661.65-337.86-23.85-1-16.27-20.29
Net Debt Issued (Repaid)
-242.0273.73109.776.9814.13-10.39
Issuance of Common Stock
2,4572,457--556.32367.31
Common Dividends Paid
-12.95-14.5-4.63-1.18-0.74-0.66
Other Financing Activities
-31.05-29.86-0.8-3.17-1.58-
Financing Cash Flow
2,1712,486104.2872.64568.12356.26

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0-0.030.060.220.04-0.07
Net Cash Flow
890.53509.04-75.57-151.58144.1592.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-770.36-666.38-220.38-224.45-424.7-263.44
Free Cash Flow Growth
------
Free Cash Flow Margin
-1441.94%-1392.31%-873.96%-925.01%-3169.45%-1032.38%
Free Cash Flow Per Share
-2.35-2.35-0.82-0.84-1.63-1.22
Levered Free Cash Flow
-323.9-1,638-101.54-222.43-387.25-136.64
Unlevered Free Cash Flow
-320.42-1,633-98.36-222.01-387.11-136.31
Free Cash Flow After Leases
-782.34-682.43-220.73-224.45-424.7-263.84

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
2.741.1-1.59-27.87-44.15-1.72
Change in Working Capital
-94.04-41.2329.0515.1962.9923.95